WHO ICTRP trial
Screening and therapeutic monitoring of multiple myeloma by MALDI-TOF MS…
ChiCTR2200066423 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2200066423 |
|---|---|
| Public title | Screening and therapeutic monitoring of multiple myeloma by MALDI-TOF MS analysis |
| Scientific title | Screening and therapeutic monitoring of multiple myeloma by MALDI-TOF MS analysis |
| Primary sponsor | Zhujiang Hospital of Southern Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Countries | China |
| Conditions | multiple myeloma |
| Interventions | case group :N/A;Control group:N/A |
| Registration date | Dec 5, 2022 |
| Target size | case group :100;Control group:100 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: